Table 5.
Side effects assessed throughout the study
| Side effects | Group | |
|---|---|---|
| Fractional CO2 | Fractional MNRF | |
| Immediately post procedure | ||
| Erythema | ||
| Present | 24 (96%) | 25 (100%) |
| Absent | 1 (04%) | 0 (00%) |
| Edema | ||
| Present | 2 (8.00%) | 12 (48%) |
| Absent | 23 (92%) | 13 (52%) |
| After 1 week | ||
| Crusting/scaling | ||
| Present | 25 (100%) | 0 (00%) |
| Absent | 0 (00%) | 25 (100%) |
| Erythema | ||
| Present | 2 (08%) | 0 (00%) |
| Absent | 23 (92%) | 25 (100%) |
| Post-therapy hyperpigmentation/hypopigmentation | ||
| Present | 6 (24%) | 1 (04%) |
| Absent | 19 (76%) | 24 (96%) |
| After 4 weeks | ||
| Post-therapy hyperpigmentation/hypopigmentation | ||
| Present | 8 (32%) | 3 (12%) |
| Absent | 17 (68%) | 22 (88%) |
| At 2 months | ||
| Post-therapy hyperpigmentation/hypopigmentation | ||
| Present | 4 (16%) | 0 (00%) |
| Absent | 21 (84%) | 25 (100%) |